Uqora Maximum UTI Pain Relief

Manufacturer
Bonafide Health, LLC dba Uqora | Pharbest Pharmaceuticals, Inc.
Effective date
2025-10-27
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:41:19

Label at a glance#

ProductUqora Maximum UTI Pain Relief
Active ingredientPHENAZOPYRIDINE HYDROCHLORIDE
Label structure8 sections

Dosage and administration

Adults and children 12 years and over: ■ take 2 tablets 3 times daily with a full glass of water, with or after meals as needed ■ Do not use for more than 2 days (12 tablets) without consulting a doctor. Children under 12 years: ■ consult a doctor

Storage and handling

■ this product may stain contact lenses ■ this product can interfere with laboratorytests including urine, glucose (sugar), and ketones tests ■ store at room temperature 15°-30°C (59°-86°F) in adry place and protect from light ■ Tamper evident: tablets sealed in blisters. Do not use if blister foil or seal isopen or damaged

Label contents#

Full prescribing information#

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Phenazopyridine Hydrochloride 99.5 mg .

Purpose

OTC - PURPOSE SECTION

Urinary Tract Analgesic

Use

INDICATIONS & USAGE SECTION

Fast relief from urinary pain, burning, urgency and frequency associated with urinary tract infections. Treatment should not exceed 2 days; see Directions.

Warnings

WARNINGS SECTION

Do not exceed recommended dosage

OTC - DO NOT USE SECTION

Do not use: if you have Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency unless approved by your physician.

OTC - ASK DOCTOR SECTION

Ask doctor before use if you have

■ kidney disease
■ allergies to foods, preservatives or dyes
■ had a hypersensitive reaction to phenazopyridine

OTC - WHEN USING SECTION

When using this product

■ stomach upset may occur, taking this product with or after meals may reduce stomach upset
■ your urine will become reddish-orange in color. This is not harmful, but care should be taken to avoid staining clothing or other items.

----

■ Long-term administration of phenazopyridine hydrochloride has induced neoplasia in rats (large intestine) andmice (liver). Although no association between phenazopyridine hydrochloride and human neoplasia has beenreported, adequate epidemiological studies along these lines have not been conducted.

OTC - STOP USE SECTION

Stop use and ask doctor if

■ your symptoms last for more than 2 days
■ you suspect you are having an adverse reaction to the medication

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of an overdose, get medical help or contact a Poison Control Center right away 1-800-222-1222.

Directions

DOSAGE & ADMINISTRATION SECTION

Adults and children 12 years and over:
■ take 2 tablets 3 times daily with a full glass of water, with or after meals as needed

■ Do not use for more than 2 days (12 tablets) without consulting a doctor.

Children under 12 years:

■ consult a doctor

Other information

STORAGE AND HANDLING SECTION

■ this product may stain contact lenses ■ this product can interfere with laboratorytests including urine, glucose (sugar), and ketones tests ■ store at room temperature 15°-30°C (59°-86°F) in adry place and protect from light ■ Tamper evident: tablets sealed in blisters. Do not use if blister foil or seal isopen or damaged

Inactive ingredients

INACTIVE INGREDIENT SECTION

corn starch, croscarmellose sodium, hypromellose, lactose, magnesium stearate,microcrystalline cellulose, polyethylene glycol, polyvinylpyrrolidone, pregelatinized starch, silicon dioxide, sodiumstarch glycolate, talc and triacetin

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

MAX STRENGTH MOST POWERFUL DOSE WITHOUT RX

uqora

FOUNDED BY A UTI SUFFERER

UTI PAIN RELIEF

MAX STRENGTH

FAST TARGETED RELIEF FOR

Burning

Pain & discomfort at the source unlike general pain relievers

Urgency

2 Day Supply

12 tablets

99.5 mg Phenazopyridine Hydrochloride

Not intended to replace medical care

11

22

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1094147phenazopyridine HCl 99.5 MG Oral TabletPSN1
1094147phenazopyridine hydrochloride 99.5 MG Oral TabletSCD1
1094147phenazopyridine HCl 99.5 MG Oral TabletSY1

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
QR code linkQR Codeqrcodes.pro/uT7ouOCARTON - 24 ct.jpg, CARTON - 12 ct.jpg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
73712-114-12Uqora Maximum UTI Pain Relief1 in 1 CARTONTABLET11
73712-114-12Uqora Maximum UTI Pain Relief12 in 1 BLISTER PACKTABLET121
73712-114-24Uqora Maximum UTI Pain Relief1 in 1 CARTONTABLET11
73712-114-24Uqora Maximum UTI Pain Relief24 in 1 BLISTER PACKTABLET241

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
73712-11473712-114-24, 73712-114-12

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 13 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
All-In-One UTI Emergency KitMETHENAMINE, SODIUM SALICYLATE, AND PHENAZOPYRIDINE HYDROCHLORIDEBonafide Health, LLC dba Uqora434652a1-583e-d6f7-e063-6394a90aab8a2025-11-10WarningsExact identifier
ndc (package): 73712-114-12
ndc11 (package): 73712011412
Uqora Maximum UTI Pain Relief and Flush Convenience BundlePHENAZOPYRIDINE HYDROCHLORIDEBonafide Health, LLC dba Uqora4354dcce-6d85-4584-e063-6294a90a56162025-11-10WarningsExact identifier
ndc (package): 73712-114-12
ndc11 (package): 73712011412
Uqora Maximum UTI Pain ReliefPHENAZOPYRIDINE HYDROCHLORIDEBonafide Health, LLC dba Uqora426317e7-a925-116a-e063-6294a90a52dc2025-10-27WarningsExact identifier
ndc (package): 73712-114-24
ndc (package): 73712-114-12
ndc (product): 73712-114
ndc11 (package): 73712011424
ndc11 (package): 73712011412
spl id: 426317e7-a926-116a-e063-6294a90a52dc
spl set id: 426317e7-a925-116a-e063-6294a90a52dc

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.